Product Details
Formula
C23H31Cl2NO3
MW
440.41
Purity
>95%
Storage (Powder)
3 Years -20°C
Storage (Solvent)
1 Year -80°C
Indication
Prostate Cancer
Mode Of Action
antagonist
Drug Status
Approved
Target Name
Microtubule-associated protein 2 (MAP2)
Research Area
CANCER
Research Area Sub Group
Anticancer
Pharmacology
STRUCTURAL
Pharmacology Area Sub Group
Cytoskeleton & Motor Proteins
Bio Chemical Notes
For the palliative treatment of patients with metastatic and/or progressive carcinoma of the prostate